2020 stock picks
in work...

​​Again, there are no big changes for stock classification. Picked biotech stocks are categorized into several groups: I) short-term investment (this will include biotech scams that can be pumped in nearest future); II) biotech gems that have strong science basis and pps below $15, potential buyouts targets for Big Pharmas; III) big cap biotechs for long-term investment (3 and more years)


I.

1) ORMP (Phase 3 start for oral insulin pills can drive pps of this scam to $15 and higher)
2) ATHE (new name for old scam biotech PRAN)
3) SRNE
4) SAVA


II.
1) CARA is still BUY, good phase 3 results for IV pain-killer can induce +50-60% spike)
2) ZIOP (buyout target for Big Pharma in 2021, possible upside +200%)​
3) ​MBII (not drugs biotech, they provide bio-based pest management and plant health products. Good enter price and huge potential)
4) AGRX
5) TRVN
6) CFRX
7) LPTX
8) SLNO
9) MRNS
10) CLVS
11)

​​
​​III.

1) NVO
2) ACAD
3) ALKS
4) ​EXEL
5)​ GBT
6) ​ IONS​
7)  SGEN
8) RARE​​
9) AIMT​
10) ABBV
11) NVCR
12) PTCT
13) KPTI
14) TGTX

to be continued...

I will avoid in 2020:


1) BLUE
4) PGEN (still "empty" biotech - just changed name from XON, just promises and speculations) 
5) XOMA
6) EDIT





Sign-Up  |  Log-In